Pioneering precision therapies for cancer & blood disorders, Kate Haviland, CEO, Blueprint Medicines by Biotech2050 Podcast published on 2023-05-25T14:18:00Z
Personalized regenerative medicines, Nabiha Saklayen, PhD, Co-Founder & CEO, Cellino by Biotech2050 Podcast published on 2023-02-03T16:57:31Z
131. Epigenetic approaches to rare diseases, Amber Salzman, CEO, Epic Bio by Biotech2050 Podcast published on 2022-12-08T14:41:11Z
Breaking barriers in rare genetic mitochondrial diseases, Greg Flesher, Pres. & CEO, Reneo by Biotech2050 Podcast published on 2023-07-11T16:34:41Z
109. Gene therapy CDMO, Tim Miller, CEO, Erandi De Silva, SVP of Prod. Dev., Forge Biologics by Biotech2050 Podcast published on 2022-05-26T15:26:59Z
JPM23 Special: Rare diseases, Eslie Dennis, Kyowa Kirin, Arthur Suckow, DTx, & James Mackay, Aristea by Biotech2050 Podcast published on 2023-01-05T15:00:23Z
Common Variable Immune Deficiency (CVID) - A Diagnosis-Specific Episode by The IDF Podcast published on 2020-03-16T19:24:35Z